Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
|
Investment Grade:
|
|
Comments(0)
|
(0)
|
(0)
|
Ranking History
Headlines
- Stock Opportunities in a 'Roadhouse Blues' Market
Nov 21, 2008 11:39 AM
- A New Index of Healthcare Cost Containment Companies
Nov 20, 2008 12:38 AM
- Five Healthcare Stocks To Diversify Your Portfolio
Nov 18, 2008 10:19 AM
- Generics Giant Teva Shines
Nov 09, 2008 01:53 PM
- Teva Beats On Profits: A Biogeneric Boon In '09?
Nov 06, 2008 09:56 AM
- Weekly Mergers and Acquisitions Report (Oct 29 - Nov 4)
Nov 04, 2008 06:26 PM
- A Bullish Outlook for Generic Drugs After Election
Nov 03, 2008 11:57 PM
- Weekly Mergers and Acquisitions Report
Oct 21, 2008 08:56 AM
- Johnson and Johnson Shines, Raises Full-Year Guidance
Oct 14, 2008 05:58 PM
- Johnson & Johnson Staying Healthy
Oct 14, 2008 04:49 PM
- Teva Q3 Net Income Rises
Nov 07, 2008 03:57 AM
- Election to benefit some industries, harm others
Nov 02, 2008 09:57 AM
- The Ticker
Aug 29, 2008 12:54 AM
- Drug Industry Flexes Muscles in New Jersey
Aug 19, 2008 02:06 PM
- Drug Industry Flexes Muscles ; Impact on State Up Even As Jobs Are Cut
Aug 19, 2008 02:00 PM
- European Indexes Finish Mixed
Aug 18, 2008 11:06 AM
- Stocks Rise As Oil Falls
Jul 30, 2008 10:54 AM
- Movers: Citigroup, Google, Barr Labs, Microsoft, Merrill Lynch
Jul 21, 2008 03:51 PM
- UPI NewsTrack Business
Jul 18, 2008 11:52 AM
- Stocks Finish Lower
Jul 08, 2008 10:55 AM
- Barr Shareholders Approve Pending Teva Acquisition
Nov 21, 2008 02:00 PM
- Teva Provides Update on Generic Pulmicort Respules® Launch
Nov 20, 2008 04:23 AM
- Teva Receives First U.S. Approval for Generic Pulmicort Respules®;
Commences Commercial Launch
Nov 19, 2008 05:09 AM
- Teva Announces Agreement on Allegra® Patent Challenge
Nov 19, 2008 01:31 AM
- Economist Finds Flaws in 14-Year Data Exclusivity Claim for
Biogenerics
Nov 18, 2008 10:57 AM
- Teva Completes Enrollment in Laquinimod Phase III Clinical Trial
Nov 18, 2008 02:20 AM
- Teva to Present at the 2008 Credit Suisse Annual Healthcare Conference
Nov 13, 2008 05:20 AM
- Teva Provides Update on Generic Prevacid(R) Litigation
Nov 07, 2008 01:18 PM
- Teva Updates 2008 Financial Outlook
Nov 06, 2008 10:24 AM
- Teva Reports Third Quarter 2008 Results
Nov 06, 2008 01:02 AM
Analyst Ratings
|
|
Share Performance
|
Period
|
TEVA
|
Compare to S&P
|
| YTD |
-10.07 %
|
55.23 %
|
| 4 Weeks |
3.36 %
|
14.92 %
|
| 12 Weeks |
-12.44 %
|
39.13 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 10.77 %
|
|
EPS Growth in Last Year: 12.50 %
|
|
Sales Growth in Last Quarter: 0.67 %
|
|
Sales Growth in Last Quarter: 20.12 %
|
|
|
